1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta]

RxCUI
2670669
RxNorm name
1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta]
Display name
1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta]
Full name
1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761134Ryzneutaefbemalenograstim alfa-vuxw351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYZNEUTAEFBEMALENOGRASTIM ALFA-VUXWAcrotech Biopharma Inc290ed754-758c-9cae-e063-6294a90ae68b2026-05-19Warnings, Adverse reactionsExact identifier
rxcui: 2670669

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
290ed754-758c-9cae-e063-6294a90ae68bRyzneuta 20 MG in 1 ML Prefilled Syringe [PSN] · 1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta] [SBD] · 1 ML Ryzneuta 20 MG/ML Prefilled Syringe [SY] · Ryzneuta 20 MG per 1 ML Prefilled Syringe [SY]47These highlights do not include all the information needed to use RYZNEUTA ®safely and effectively. See full prescribing information for RYZNEUTA. RYZNEUTA ®(efbemalenograstim alfa-vuxw) injection, for subcutaneous use Initial U.S. Approval: 202320260519